You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 |
格隆匯 02-24 13:34
格隆匯2月24日丨九強生物(300406.SZ)逼近漲停,報21.38元,總市值107億元。九強生物2月19日晚間公告,調整非公開發行股票方案。發行價格調整為不低於定價基準日前20個交易日公司股票交易均價的80%,具體為13.9元/股。據此發行價格計算,此次發行股票數量為不超過8633萬股,不超過發行前公司總股本的30%。限售期調整為18個月內。募資總額不超過12億元。機構預計該資金後續將用於公司收購邁新生物,將為該重大收購事項順利落地提供資金基礎。以發行價格13.9元/股計算,國藥投資將持有發行後總股本的14.7%,成為公司單一第一大股東,將為公司注入國藥系資源奠定基礎,打開公司未來發展想象空間。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account